Establishment and Characterization of a New Ph1-Positive Chronic Myeloid Leukemia Cell Line MC3 with Trilineage Phenotype and an Altered p53 Gene
- 1 January 1995
- journal article
- case report
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 16 (5-6), 493-503
- https://doi.org/10.3109/10428199509054439
Abstract
A new Ph1-positive leukemic cell line (MC3) expressing the P210ber/abl oncoprotein was established from a patient with CML in blast crisis. The MC3 cells showed the trilineage phenotype of myeloid, lymphoid (CD 19) and megakaryocytoid lineages, and had a proliferative response to rhIL-1 and rhIL-3 in the serum-free culture. These results and the expression of CD34 indicated that the MC3 cells have characteristics of hematopoietic progenitor cells. Recently, it has been documented that alterations of the p53 gene in leukemic cells are frequently detected during the blast crisis of CML. The MC3 cells contained the altered p53 gene. In addition, the original leukemic cells showed the point-mutational activation of the N-ras gene and an additional chromosomal abnormality inv(3q), but the MC3 cells contained no such abnormalities, indicating that not all of the original leukemic cells had these abnormalities. Thus, the MC3 cell line may provide several insights into investigations of the blast crisis in CML as well as hematopoietic progenitor cells.Keywords
This publication has 29 references indexed in Scilit:
- BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent mannerCell, 1991
- The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.Journal of Clinical Investigation, 1991
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990
- Rare occurrence of N-ras point mutations in Philadelphia chromosome positive chronic myeloid leukemiaBlood, 1989
- Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.Proceedings of the National Academy of Sciences, 1988
- Transforming genes in chronic myelogenous leukemia.Proceedings of the National Academy of Sciences, 1988
- Chronic myelogenous leukemia: amplification of a rearranged c-abl oncogene in both chronic phase and blast crisisBlood, 1987
- An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activityCell, 1984
- Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22Cell, 1984
- Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemiaNature, 1983